This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, at a ceiling value of $15,761.76. The delivery order has a firm fixed price pricing structure and runs through June 11, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $12,567.70, is for the provision of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product. The contract is a firm fixed-price delivery order, with a period of performance running through March 6, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $1,256.77 and has an ultimate completion date of March 11, 2025. The contract is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,640.30 award is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, with a completion date of June 1, 2022. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $81,476.40 contract is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a specialized medication product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,027.12 contract is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities. The contract is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA 2 MG/0.05 ML VIAL 0.05ML. This delivery order, valued at $5,253.92, has a completion date of February 1, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of pharmaceutical and medical products to support military treatment facilities worldwide through various DLA contracts and indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) under the SPE2DB program to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,291.93, is for the delivery of EYLEA 2MG/0.05ML SY 1S, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. The contract has a firm fixed-price pricing type and a completion date of May 15, 2024. DMS Pharmaceutical Group Inc. has a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product EYLEA 2 MG/0.05 ML VIAL 0.05ML. This delivery order, valued at $134,355.50, was issued against an existing indefinite delivery contract between DMS Pharmaceutical Group and DLA to supply various medical supplies and pharmaceutical products to support military treatment facilities globally. The delivery order has a...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) under the SPE2DB program. The order, valued at $10,507.84, is for the supply of 4565890428 - EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product. The order has an ultimate completion date of October 8, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up...